Urine analysis helps to identify and treat patients with substance addiction and there is a need to develop interventions in patients with positive urine drug test to keep them engaged in care

‘Health care providers should monitor patients for illicit substance use through urine drug testing to provide adequate addiction treatment.’
Read More..

Published in Drug and Alcohol Dependence, the study indicates the need to develop interventions for patients who have positive urine drug tests in order to keep them engaged in care.Read More..





Office-based addiction treatment has become a key strategy in combating the opioid epidemic in the United States, where patients get treatment for their disease in a primary care setting with close monitoring during their recovery.
However, one of the questions in the current practice of is how best to monitor for illicit substance use, especially when patients do not report it. There has also been a lack of data regarding how frequently patients in these programs report substance use compared to finding a positive result by urine drug testing (UDT).
"It is important for providers to understand more about how the lab results compare to what patients tell us in a visit," said Sarah M. Bagley, MD, the study's co-author who is an internist and pediatrician at BMC and assistant professor of medicine and pediatrics at Boston University School of Medicine.
The researchers correlated the frequency of patients' self-reported substance use and the results of their UDTs. It showed that 76 percent of UDTs positive for cocaine and 57 percent of those positive for opioids occurred when patients did not disclose substance use in their treatment visit.
Advertisement
"Patients may not be self-reporting substance use early on in their treatment due to concerns about being discharged from programs if they disclose use, or they may feel shame about relapse and do not want to disappoint their care team", said Bagley, who also serves as director of BMC's CATALYST Clinic for treatment of addiction in adolescents and young adults.
Advertisement
Source-Eurekalert